Evidence map›Paper›PMID 35208164›Full record

ArticleMetabolites2022

Crosstalk between Acidosis and Iron Metabolism: Data from In Vivo Studies.

Raêd Daher, Nicolas Ducrot, Thibaud Lefebvre, Sofia Zineeddine, Jérome Ausseil, Hervé Puy, Zoubida Karim

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Acidosis, Iron Dyshomeostasis and Inflammatory Injury.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Raêd DaherCentre de Recherche sur l'Inflammation (CRI), Université de Paris, INSERM, CNRS, F-75018 Paris, France.
Nicolas DucrotCentre de Recherche sur l'Inflammation (CRI), Université de Paris, INSERM, CNRS, F-75018 Paris, France.
Thibaud LefebvreCentre de Recherche sur l'Inflammation (CRI), Université de Paris, INSERM, CNRS, F-75018 Paris, France.
Sofia ZineeddineCentre de Recherche sur l'Inflammation (CRI), Université de Paris, INSERM, CNRS, F-75018 Paris, France.
Jérome AusseilInstitut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université de Toulouse, INSERM, CNRS, F-31024 Toulouse, France.
Hervé PuyCentre de Recherche sur l'Inflammation (CRI), Université de Paris, INSERM, CNRS, F-75018 Paris, France.
Zoubida KarimCentre de Recherche sur l'Inflammation (CRI), Université de Paris, INSERM, CNRS, F-75018 Paris, France.ORCID 0000-0002-3724-5592
Centre National de la Recherche Scientifique · FR

Funding

Investissements d'avenir ANR-11-IDEX-0005-02labex GR-Ex ANR-11-LABX-0051
6 · The paper itself

Abstract

Iron absorption requires an acidic environment that is generated by the activity of the proton pump gastric H(+)/K(+)ATPase (ATP4), expressed in gastric parietal cells. However, hepcidin, the iron regulatory peptide that inhibits iron absorption, unexpectedly upregulates ATP4 and increases gastric acidity. Thus, a concept of link between acidosis and alterations in iron metabolism, needs to be explored. We investigated this aspect in-vivo using experimental models of NH4Cl-induced acidosis and of an iron-rich diet. Under acidosis, gastric ATP4 was augmented. Serum hepcidin was induced and its mRNA level was increased in the liver but not in the stomach, a tissue where hepcidin is also expressed. mRNA and protein levels of intestinal DMT1(Divalent Metal Transporter 1) and ferroportin were downregulated. Serum iron level and transferrin saturation remained unchanged, but serum ferritin was significantly increased. Under iron-rich diet, the protein expression of ATP4A was increased and serum, hepatic and gastric hepcidin were all induced. Taken together, these results provide evidence of in-vivo relationship between iron metabolism and acidosis. For clinical importance, we speculate that metabolic acidosis may contribute in part to the pathologic elevation of serum hepcidin levels seen in patients with chronic kidney disease. The regulation of ATP4 by iron metabolism may also be of interest for patients with hemochromatosis.

Indexed as

acidosisacid secretionATP4hepcidiniron metabolism

Identifiers

PMID35208164
PMCPMC8874512
OpenAlexW4206749855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.